Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMC1 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | NDUFS7 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | PABPC4L | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | WRN | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | HBG2 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | KEL | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | MYB | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |
mRNA | DPAGT1 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
mRNA | HBG1 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | CARD8 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |